1FIB | A:144-286,A:381-391 | RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) BOUND TO CALCIUM AT PH 6.0 |
1FIC | A:144-286,A:381-403; B:144-286,B:381-401 | STRUCTURE OF HUMAN GAMMA FIBRINOGEN 30 KD CARBOXYL TERMINAL FRAGMENT |
1FID | A:144-286,A:381-401 | STRUCTURE OF HUMAN GAMMA FIBRINOGEN 30 KD CARBOXYL TERMINAL FRAGMENT |
1FZA | C:144-286,C:381-391; F:144-286,F:381-391; B:202-349,B:449-459; E:202-349,E:449-459 | CRYSTAL STRUCTURE OF FIBRINOGEN FRAGMENT D |
1FZB | C:144-286,C:381-391; F:144-286,F:381-391; B:202-349,B:449-459; E:202-349,E:449-459 | CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D |
1FZC | C:144-286,C:381-391; B:202-349,B:449-458; E:202-349,E:449-458; F:144-286,F:381-391 | CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO DIFFERENT BOUND LIGANDS |
1FZD | A:651-750,A:837-847; B:651-750,B:837-847; C:651-750,C:837-847; D:651-750,D:837-847; E:651-750,E:837-847; F:651-750,F:837-847; G:651-750,G:837-847; H:651-750,H:837-847 | STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420 |
1FZE | C:144-286,C:381-391; F:144-286,F:381-391; E:202-349,E:449-458; B:202-349,B:449-459 | CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN |
1FZF | C:144-286,C:381-391; B:202-349,B:449-459; E:202-349,E:449-459; F:144-286,F:381-391 | CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE |
1FZG | C:144-286,C:381-391; B:202-349,B:449-458; E:202-349,E:449-458; F:144-286,F:381-391 | CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE |
1LT9 | C:144-286,C:381-391; F:144-286,F:381-391; B:202-349,B:449-458; E:202-349,E:449-458 | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D |
1LTJ | C:144-286,C:381-391; F:144-286,F:381-391; B:202-349,B:449-458; E:202-349,E:449-458 | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGANDS GLY-PRO-ARG-PRO-AMIDE AND GLY-HIS-ARG-PRO-AMIDE |
1N86 | C:144-286,C:381-391; F:144-286,F:381-391; B:202-349,B:449-457; E:202-349,E:449-457 | CRYSTAL STRUCTURE OF HUMAN D-DIMER FROM CROSS-LINKED FIBRIN COMPLEXED WITH GPR AND GHRPLDK PEPTIDE LIGANDS. |
1RE3 | C:144-286,C:381-391; B:165-356,B:447-458; E:159-356,E:447-459; F:144-286,F:381-391 | CRYSTAL STRUCTURE OF FRAGMENT D OF BBETAD398A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE |
1RE4 | C:144-286,C:381-391; B:202-349,B:449-459; E:166-356,E:447-459; F:144-286,F:381-391 | CRYSTAL STRUCTURE OF FRAGMENT D OF BBETAD398A FIBRINOGEN |
1RF0 | C:144-286,C:381-391; F:144-286,F:381-391; E:202-349,E:449-459; B:154-356,B:447-459 | CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAE132A FIBRINOGEN |
1RF1 | C:144-286,C:381-391; B:202-349,B:449-459; E:202-349,E:449-459; F:144-286,F:381-391 | CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAE132A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE |
1Z3S | A:280-410,A:486-495; B:280-410,B:486-495 | ANGIOPOIETIN-2 RECEPTOR BINDING DOMAIN |
1Z3U | A:280-410,A:486-495; B:280-410,B:486-495; C:280-410,C:486-495; D:280-410,D:486-495 | STRUCTURE OF THE ANGIOPOIETIN-2 RECPTOR BINDING DOMAIN AND IDENTIFICATION OF SURFACES INVOLVED IN TIE2 RECOGNITION |
2D39 | A:113-244,A:318-326; B:114-244,B:318-326; C:115-244,C:318-326 | TRIVALENT RECOGNITION UNIT OF INNATE IMMUNITY SYSTEM; CRYSTAL STRUCTURE OF HUMAN M-FICOLIN FIBRINOGEN-LIKE DOMAIN |
2FFD | C:144-286,C:381-391; F:144-286,F:381-391; B:202-349,B:449-459; E:202-349,E:449-459 | FIBRINOGEN FRAGMENT D WITH "A" KNOB PEPTIDE MIMIC GPRVVE |
2FIB | A:144-286,A:381-391 | RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) COMPLEXED TO THE PEPTIDE GLY-PRO-ARG-PRO AT PH 6.0 |
2GY7 | A:280-410,A:486-495 | ANGIOPOIETIN-2/TIE2 COMPLEX CRYSTAL STRUCTURE |
2H43 | C:144-286,C:381-392; F:144-286,F:381-392; B:202-349,B:449-458; E:202-349,E:449-458 | CRYSTAL STRUCTURE OF HUMAN FRAGMENT D COMPLEXED WITH ALA-HIS-ARG-PRO-AMIDE |
2HLO | F:144-286,F:381-391; C:144-286,C:381-393; B:202-349,B:449-459; E:202-349,E:449-459 | CRYSTAL STRUCTURE OF FRAGMENT D-DIMER FROM HUMAN FIBRIN COMPLEXED WITH GLY-HYDROXYPRO-ARG-PRO-AMIDE |
2HOD | C:144-286,C:381-391; F:144-286,F:381-391; I:144-286,I:381-391; L:144-286,L:381-391; B:202-349,B:449-457; E:202-349,E:449-457; H:202-349,H:449-457; K:202-349,K:449-457 | CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN COMPLEXED WITH GLY-HYDROXYPRO-ARG-PRO-AMIDE |
2HPC | C:144-286,C:381-391; F:144-286,F:381-391; I:144-286,I:381-391; L:144-286,L:381-391; B:202-349,B:449-457; E:202-349,E:449-457; H:202-349,H:449-457; K:202-349,K:449-457 | CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN COMPLEXED WITH GLY-PRO-ARG-PRO-AMIDE. |
2J0G | E:71-206,E:280-288; B:72-206,B:280-288; C:73-206,C:280-288; D:75-206,D:280-288; A:76-206,A:280-287; F:77-206,F:280-288 | L-FICOLIN COMPLEXED TO N-ACETYL-MANNOSAMINE |
2J0H | E:71-206,E:280-288; B:72-206,B:280-288; C:73-206,C:280-288; A:75-206,A:280-288; D:75-206,D:280-288; F:77-206,F:280-288 | L-FICOLIN COMPLEXED TO ACETYL-CHOLINE |
2J1G | E:71-206,E:280-288; B:72-206,B:280-288; F:72-206,F:280-288; C:73-206,C:280-288; D:75-206,D:280-288; A:76-206,A:280-287 | L-FICOLIN COMPLEXED TO N-ACETYL-CYSTEIN |
2J2P | B:71-206,B:280-288; E:71-206,E:280-288; A:75-206,A:280-288; D:75-206,D:280-288; C:77-206,C:280-288; F:77-206,F:280-288 | L-FICOLIN COMPLEXED TO N-ACETYL-CYSTEIN (150MM) |
2J3F | A:70-206,A:280-288; B:72-206,B:280-288; D:72-206,D:280-288; E:72-206,E:280-288; F:72-206,F:280-288; C:75-206,C:280-288 | L-FICOLIN COMPLEXED TO N-ACETYL-D-GALACTOSAMINE |
2J3G | E:71-206,E:280-288; B:72-206,B:280-288; D:72-206,D:280-288; F:75-206,F:280-288; A:76-206,A:280-288; C:76-206,C:280-288 | L-FICOLIN |
2J3O | B:70-206,B:280-288; A:72-206,A:280-288; C:72-206,C:280-288; E:72-206,E:280-288; F:72-206,F:280-288; D:72-206,D:280-287 | L-FICOLIN COMPLEXED TO N-ACETYL-D-GLUCOSAMINE |
2J3U | B:71-206,B:280-288; E:71-206,E:280-288; A:72-206,A:280-288; F:72-206,F:280-288; D:73-206,D:280-288; C:75-206,C:280-288 | L-FICOLIN COMPLEXED TO GALACTOSE |
2J5Z | A:63-196,A:270-276; B:66-196,B:270-276; C:66-196,C:270-276 | H-FICOLIN COMPLEXED TO GALACTOSE |
2J60 | A:63-196,A:270-276; B:64-196,B:270-276; C:66-196,C:270-276 | H-FICOLIN COMPLEXED TO D-FUCOSE |
2J61 | B:73-206,B:280-288; A:73-206,A:280-288 | L-FICOLIN COMPLEXED TO N-ACETYLGLUCOSAMINE (FORME C) |
2J64 | A:11-141,A:215-221; B:11-141,B:215-221; C:11-141,C:215-221 | H-FICOLIN |
2JHH | C:81-215,C:289-297; F:81-215,F:289-297 | STRUCTURE OF GLOBULAR HEADS OF M-FICOLIN AT ACIDIC PH |
2JHI | F:81-215,F:289-297 | STRUCTURE OF GLOBULAR HEADS OF M-FICOLIN COMPLEXED WITH N-ACETYL-D-GALACTOSAMINE |
2JHK | F:81-215,F:289-297 | STRUCTURE OF GLOBULAR HEADS OF M-FICOLIN COMPLEXED WITH N-ACETYL-D-GLUCOSAMINE |
2JHL | F:81-215,F:289-297 | STRUCTURE OF GLOBULAR HEADS OF M-FICOLIN COMPLEXED WITH SIALIC ACID |
2JHM | F:81-215,F:289-297 | STRUCTURE OF GLOBULAR HEADS OF M-FICOLIN AT NEUTRAL PH |
2OYH | C:144-286,C:381-391; B:202-349,B:449-458; E:202-349,E:449-459; F:144-286,F:381-391 | CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAD298,301A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE |
2OYI | C:144-286,C:381-391; B:202-349,B:449-458; E:202-349,E:449-458; F:144-286,F:381-391 | CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAD298,301A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-PRO-ARG-PRO-AMIDE |
2Q9I | F:144-286,F:381-391; C:144-286,C:381-393; B:202-349,B:449-459; E:202-349,E:449-459 | CRYSTAL STRUCTURE OF D-DIMER FROM HUMAN FIBRIN COMPLEXED WITH MET-HIS-ARG-PRO-TYR-AMIDE. |
2WNP | F:81-215,F:289-297 | M-FICOLIN MUTANT Y271F |
2Z4E | F:144-286,F:381-391; C:144-286,C:381-393; B:202-349,B:449-459; E:202-349,E:449-459 | CRYSTAL STRUCTURE OF D-DIMER FROM HUMAN FIBRIN COMPLEXED WITH GLY-HIS-ARG-PRO-TYR-AMIDE |
3BVH | C:144-286,C:381-394; F:144-286,F:381-394; B:202-349,B:449-458; E:202-349,E:449-458 | CRYSTAL STRUCTURE OF RECOMBINANT GAMMAD364A FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGAND GLY-PRO-ARG-PRO-AMIDE |
3E1I | C:144-286,C:381-391; B:202-349,B:449-458; E:202-349,E:449-458; F:144-286,F:381-391 | CRYSTAL STRUCTURE OF BBETAD432A VARIANT FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE |
3FIB | A:144-286,A:381-391 | RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) BOUND TO CALCIUM AT PH 6.0: A FURTHER REFINEMENT OF PDB ENTRY 1FIB, AND DIFFERS FROM 1FIB BY THE MODELLING OF A CIS PEPTIDE BOND BETWEEN RESIDUES K338 AND C339 |
3GHG | C:144-286,C:381-391; F:144-286,F:381-391; I:144-286,I:381-391; L:144-286,L:381-391 | CRYSTAL STRUCTURE OF HUMAN FIBRINOGEN |